Measles virus-induced suppression of immune responses.

Immunological Reviews
Diane E Griffin

Abstract

Measles is an important cause of child mortality that has a seemingly paradoxical interaction with the immune system. In most individuals, the immune response is successful in eventually clearing measles virus (MV) infection and in establishing life-long immunity. However, infection is also associated with persistence of viral RNA and several weeks of immune suppression, including loss of delayed type hypersensitivity responses and increased susceptibility to secondary infections. The initial T-cell response includes CD8+ and T-helper 1 CD4+ T cells important for control of infectious virus. As viral RNA persists, there is a shift to a T-helper 2 CD4+ T-cell response that likely promotes B-cell maturation and durable antibody responses but may suppress macrophage activation and T-helper 1 responses to new infections. Suppression of mitogen-induced lymphocyte proliferation can be induced by lymphocyte infection with MV or by lymphocyte exposure to a complex of the hemagglutinin and fusion surface glycoproteins without infection. Dendritic cells (DCs) are susceptible to infection and can transmit infection to lymphocytes. MV-infected DCs are unable to stimulate a mixed lymphocyte reaction and can induce lymphocyte unresponsivenes...Continue Reading

References

Jun 1, 1977·The Journal of Pediatrics·J J IacuoneB C Lampkin
Feb 1, 1978·Journal of Virology·J M Hardwick, R H Bussell
Oct 1, 1992·International Journal of Epidemiology·C MillerK Harbert
Feb 1, 1992·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·R LeopardiR Vainionpää
Jun 24, 1992·Biochimica Et Biophysica Acta·O A VanderpuyeJ A McIntyre
Apr 1, 1990·The Journal of Clinical Investigation·G HarroweD G Payan
Aug 1, 1990·Clinical and Experimental Immunology·D E GriffinA Vaisberg
Jan 1, 1991·Reviews of Infectious Diseases·D E Griffin
Nov 1, 1991·Clinical Immunology and Immunopathology·B J WardD E Griffin
Jun 22, 1989·The New England Journal of Medicine·D E GriffinA Vaisberg
Apr 1, 1984·Clinical Immunology and Immunopathology·R L HirschA Vaisberg
Jan 1, 1983·Infection and Immunity·P Arneborn, G Biberfeld
Apr 1, 1980·American Journal of Epidemiology·N A HalseyD D Ludwig
Nov 1, 1995·The Journal of Clinical Investigation·L M EsolenD E Griffin
Nov 1, 1995·The Journal of General Virology·S KranticC Rabourdin-Combe
Jul 20, 1995·Nature·B G CocksG Aversa
Oct 1, 1993·Molecular Immunology·R W JohnstoneI F McKenzie
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·J Schneider-SchauliesV ter Meulen
Jun 1, 1995·Journal of Virology·L M EsolenD E Griffin
Nov 1, 1994·The Journal of Infectious Diseases·D E GriffinL M Esolen
Aug 1, 1994·The Journal of Infectious Diseases·R S van BinnendijkA D Osterhaus
Aug 1, 1993·The Journal of Infectious Diseases·D E Griffin, B J Ward
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·J SchlenderS Schneider-Schaulies

❮ Previous
Next ❯

Citations

May 20, 2011·Journal of Virology·Ibrahim BoussaadSibylle Schneider-Schaulies
Jan 29, 2011·Journal of Virology·Kerstin M SchuhmannKarl-Klaus Conzelmann
Nov 11, 2011·Journal of Virology·Konstantin M J SparrerKarl-Klaus Conzelmann
Jan 27, 2012·Journal of Virology·Mohammed A SarhanTomasz I Michalak
Mar 22, 2013·Journal of Translational Medicine·Marta CurriuJulià Blanco
Dec 21, 2012·Virology Journal·Shiril KumarJean-Jacques Hoarau
Sep 7, 2012·PLoS Pathogens·Rory D de VriesRik L de Swart
Oct 3, 2013·PLoS Pathogens·Clémence RichettaMathias Faure
May 25, 2011·Drug Design, Development and Therapy·Laëtitia Michou, Jacques P Brown
Nov 4, 2011·Viruses·Elita AvotaSibylle Schneider-Schaulies
Apr 20, 2014·Genome Announcements·Konstantin M J SparrerKarl-Klaus Conzelmann
Aug 6, 2014·Proceedings of the National Academy of Sciences of the United States of America·Dan YanRichard Karl Plemper
Apr 7, 2012·Cellular and Molecular Life Sciences : CMLS·Rolf M Zinkernagel
Apr 2, 2014·Expert Review of Clinical Immunology·Sai S DuraisinghamHilary J Longhurst
Dec 7, 2013·Expert Opinion on Drug Discovery·Richard K Plemper, Anthea L Hammond
Aug 5, 2015·Journal of Clinical Pharmacology·Philip Zachariah, Melissa S Stockwell
Nov 19, 2015·Frontiers in Immunology·Ingrid M SchellensCécile A C M van Els
Jan 3, 2013·Reviews in Medical Virology·Melissa M CoughlinPaul A Rota
Dec 25, 2010·European Journal of Immunology·Hieu Tran-VanSibylle Schneider-Schaulies
Jul 20, 2010·Immunological Reviews·Philippa MarrackMegan K L MacLeod
Oct 9, 2014·The Journal of Pathology·Martin LudlowW Paul Duprex
Aug 23, 2011·Lancet·William J Moss, Diane E Griffin
Mar 10, 2015·The Journal of Molecular Diagnostics : JMD·Siddharth SridharKwok-Yung Yuen
Jan 13, 2015·La Revue de médecine interne·M CaserisV Joly
Dec 18, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Rupak ShivakotiDiane E Griffin
Dec 23, 2011·Vaccine·Douglas C Hodgins, Patricia E Shewen
Apr 17, 2013·Virology·Manisha GuptaChristina F Spiropoulou
Sep 1, 2014·Journal of the Pediatric Infectious Diseases Society·Jaap Ten OeverAdriana Slavcovici
Dec 19, 2014·PLoS Pathogens·Rory D de Vries, Rik L de Swart
Aug 2, 2016·Comparative Immunology, Microbiology and Infectious Diseases·Fuxiao LiuZhiliang Wang
Aug 21, 2016·Social Science & Medicine·Helen C S MeierAllison E Aiello
Aug 3, 2016·Viruses·Brigitta M LaksonoRik L de Swart
May 23, 2017·Viruses·Denitsa S PetkovaMathias Faure
Apr 17, 2017·Allergologia et immunopathologia·A Tak ManeshA Aghamohammadi
Jul 14, 2017·Pediatric Pulmonology·Thuy Thi Bich PhungNoriko Nakajima
Aug 12, 2017·International Journal of Molecular Sciences·Nicolás M S GálvezAlexis M Kalergis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.